Skip to main content

Advertisement

Log in

Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI

  • Contrast Media
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objective

To evaluate the reliability of contrast-enhanced ultrasound quantitative analysis (CE-US) in characterizing breast lesions, in comparison with MRI.

Materials

Thirty-nine patients with breast lesions BI-RADS 3–5 at US or mammography underwent CE-US and MRI. All lesions underwent histological and quantitative enhancement evaluation with both imaging methods. B-mode US, colour/power Doppler US and CE-US were used; an amplitude and phase modulation technique (CPS) read the signals produced by microbubbles and dedicated software produced the following parameters on time/intensity (T/I) curves: peak %, time to peak (TTP), mean transit time (MTT), regional blood volume (RBV) and regional blood flow (RBF). Student’s t test was used to calculate the diagnostic accuracy of CE-US parameters compared with histological results. MRI (1.5 T) was performed before and after bolus gadolinium enhancement. Time/intensity curves were generated for all nodules and Fischer’s multimodal score was used to classify them.

Results

Pathology showed 43 nodules (11 benign; 32 malignant). Peak and RBF were the most significant parameters in differential diagnosis, with p values of 0.02 and 0.004, respectively. Positive predictive value (PPV) of CE-US evaluation was 91%, negative predictive value (NPV) was 73% with a high concordance index (k = 0.59) with MRI.

Conclusions

CE-US quantitative analysis offers an objective and reproducible assessment of lesion vascularisation, with good correlation with the results of MRI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Fauci AS, Braunwald E, Isselbacher KJ et al (1999) Harrison: principles of internal medicine, vol 1, 14th edn. McGraw-Hill, New York

    Google Scholar 

  2. Crystal P, Strano S, Shcharynski S et al (2003) Using sonography to screen women with mammographically dense breasts. Am J Roentgenol 181:177–182

    Google Scholar 

  3. Bick U, Diekmann F (2007) Digital mammography: what do we and what don’t we know? Eur Radiol 17:1931–1942

    Article  PubMed  Google Scholar 

  4. Özdemir A, Özdemir H, Maral I et al (2001) Differential diagnosis of solid breast lesions. Contribution of doppler studies to mammography and gray scale imaging. J Ultrasound Med 20:1091–1101

    PubMed  Google Scholar 

  5. Italian Society of Medical Radiology (2004) Charta senologica. Diagnostic approach to breast diseases. Radiol Med 108:569–587

    Google Scholar 

  6. Corsetti V, Ferrari A, Ghirardi M (2006) Role of ultrasonography in detecting mammographically occult breast carcinoma in women with dense breasts. Radiol Med 111:440–448

    Article  CAS  PubMed  Google Scholar 

  7. Bonadonna G, Robustelli della Cuna G (1999) Medicina oncologica, 6th edn. Masson, Milan

    Google Scholar 

  8. Passariello R, Simonetti G (2000) Compendio di radiologia. Idelson-Gnocchi, Naples

    Google Scholar 

  9. Chapellier C, Balu-Maestro C, Bleuse A et al (2000) Ultrasonography of invasive lobular carcinoma of the breast. Sonographic patterns and diagnostic value. Report of 102 cases. J Clin Imaging 24:333–336

    Article  CAS  Google Scholar 

  10. Hylton N et al (2005) Magnetic resonance imaging of the breast: opportunities to improve breast cancer management. J Clin Oncol 23:1678–1684

    Article  PubMed  Google Scholar 

  11. Folkman J, Klagsbrun M (1987) Angiogenetic factors. Science 235:442–447

    Article  CAS  PubMed  Google Scholar 

  12. Baum F, Fischer U, Vosshenrich, Grabbe E (2002) Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 12:1087–1092

  13. Orel S (1999) Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: are time–signal intensity curves an accurate predictor? Radiology 211:5–7

    CAS  PubMed  Google Scholar 

  14. EFSUMB Study Group (2004) Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 25:249–256

    Article  Google Scholar 

  15. Quaia E, Stacul F, Gaiani S et al (2004) Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers. Radiol Med 108:71–81

    PubMed  Google Scholar 

  16. Guazzaroni M, Cossu E, Danese V et al (1998) Use of SHU 508 A Levovist contrast media in the characterization of solid lesions of the breast. Radiol Med 96:35–41

    CAS  PubMed  Google Scholar 

  17. Caruso G, Ienzi R, Cirino A et al (2002) Breast lesion characterization with contrast-enhanced US. Work in progress. Radiol Med 104:443–450

    PubMed  Google Scholar 

  18. Ricci P, Cantisani V, Ballesio L et al (2007) Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging. Ultraschall Med 28:57–62

    Article  CAS  PubMed  Google Scholar 

  19. Clevert DA, Jung EM, Jungius KP et al (2007) Value of tissue harmonic imaging (THI) and contrast harmonic imaging (CHI) in detection and characterization of breast tumours. Eur Radiol 17:1–10

    Article  PubMed  Google Scholar 

  20. Alamo L, Fischer U (2001) Contrast-enhanced color Doppler ultrasound characteristics in hypervascular breast tumors: comparison with MRI. Eur Radiol 11:970–977

    Article  CAS  PubMed  Google Scholar 

  21. Schröder RJ, Bostanjoglo M, Rademaker J et al (2003) Role of power Doppler techniques and ultrasound contrast enhancement in the differential diagnosis of focal breast lesions. Eur Radiol 13:68–79

    Google Scholar 

  22. Schröder RJ, Bostanjoglo M, Hidajat N et al (2002) Analysis of vascularity in breast tumors: comparison of high frequency ultrasound and contrast-enhanced color harmonic imaging. Rofo 174:1132–1141

    PubMed  Google Scholar 

  23. American College of Radiology (ACR) (2003) Breast imaging reporting and data system Atlas (BI-RADS® Atlas). ACR, Reston

    Google Scholar 

  24. Bewick V, Cheek L, Ball J (2004) Review. Statistics review 13: receiver operating characteristic curves. Crit Care 8(6)

  25. Buadu LD, Murakami J, Murayama S et al (1996) Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 200:639–649

    CAS  PubMed  Google Scholar 

  26. Greis C (2004) Technology overview: SonoVue (Bracco, Milan). Eur Radiol Suppl 14:P11–P15

    Article  Google Scholar 

  27. Kettenbach J, Helbich T, Huber S et al (2005) Computer-assisted quantitative assessment of power Doppler US: effects of microbubble contrast agent in the differentiation of breast tumors. Eur J Radiol 53:238–244

    Article  PubMed  Google Scholar 

  28. Yang WT, Metreweli C, Lam PKW et al (2001) Benign and malignant breast masses and axillary nodes: evaluation with echo-enhanced color power doppler US. Radiology 220:795–802

    Article  CAS  PubMed  Google Scholar 

  29. Stuhrmann M, Aronius R, Schietzel M (2000) Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced doppler sonography. Am J Roentgenol 175:1585–1589

    CAS  Google Scholar 

  30. Reinikainen H, Pääkkö E, Suramo I et al (2002) Dynamics of contrast enhancement in MR imaging and power doppler ultrasonography of solid breast lesions. Acta Radiol 43:492–500

    Article  CAS  PubMed  Google Scholar 

  31. Huber S, Helbich T, Kettenbach J et al (1998) Effect of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color doppler US—early experience. Radiology 208:485–489

    CAS  PubMed  Google Scholar 

  32. Kedar RP, Cosgrove D, McCready VR et al (1996) Microbubble contrast agent for color Doppler US: effect on breast masses—work in progress. Radiology 198:679–686

    CAS  PubMed  Google Scholar 

  33. Reinikainen H, Rissanen T, Päivänsalo M et al (2001) B-mode, power Doppler and contrast-enhanced power Doppler ultrasonography in the diagnosis of breast tumors. Acta Radiol 42:106–113

    Article  CAS  PubMed  Google Scholar 

  34. Kook SH, Kwang HJ (2003) Value of contrast-enhanced power Doppler sonography using a microbubble echo-enhancing agent in evaluation of small breast lesions. J Clin Ultrasound 31:227–238

    Article  PubMed  Google Scholar 

  35. Fischer U (2004) Practical MR mammography. Thieme, Stuttgart

    Google Scholar 

  36. Caumo F, Carbognin G, Casarin A et al (2006) Angiosonography in suspicious breast lesions with non-diagnostic FNAC: comparison with power Doppler US. Radiol Med 111:61–72

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Natalia Caproni or Pietro Torricelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caproni, N., Marchisio, F., Pecchi, A. et al. Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI. Eur Radiol 20, 1384–1395 (2010). https://doi.org/10.1007/s00330-009-1690-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-009-1690-1

Keywords

Navigation